This schematic illustration shows how a human therapeutic gene is inserted into a deactivated mouse retrovirus. The retrovirus then attaches to and empties its genetic material into a patient's cell (in the laboratory). The therapeutic human gene is integrated into the patient's DNA and replaces the 'defective' gene, in the treatment for ADA. Illustration by Jeannie Kelly.